Skip to content
Top Globe News – Lifestyle
Author:
RQ Bio
RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
June 24, 2026